Multi-Analyte, Genetic, and Thrombogenic Markers of Atherosclerosis (MAGMA)

This study is currently recruiting participants.
Verified November 2013 by LifeBridge Health
Sponsor:
Collaborators:
Accumetrics, Inc.
Nanosphere, Inc.
Information provided by (Responsible Party):
Kevin Bliden, LifeBridge Health
ClinicalTrials.gov Identifier:
NCT01276678
First received: January 11, 2011
Last updated: November 5, 2013
Last verified: November 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: December 2014
  Estimated Primary Completion Date: June 2014 (Final data collection date for primary outcome measure)